Company / Operating Income
RHYTHM PHARMACEUTICALS, INC. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$192.0M
FY2025
5-year range
-$265.5M / -$170.1M
FY2021-FY2025
Trend
+27.7%
vs FY2024
Sector context
#141 of 204
Health Care
What the data says
At -$192M, RHYTHM PHARMACEUTICALS, INC.'s operating income ranks #141 of 204 in the Health Care sector. Operating Income returned to growth in FY2025 after 4 years of decline, reaching -$192M.
Based on SEC 10-K filings.
-$192M in FY2025.
Declined from -$184M to -$192M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#141 of 204 in Health CareTop 69% of 204This company -$192.0M Sector average $107.7M
▼
-278.3% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 27.7% year-over-year.
- Ranks #141 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2016.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$192.0M | +27.7% |
| FY2024 | -$265.5M | -44.0% |
| FY2023 | -$184.4M | -2.9% |
| FY2022 | -$179.2M | -5.3% |
| FY2021 | -$170.1M | -24.5% |
| FY2020 | -$136.6M | +6.5% |
| FY2019 | -$146.0M | -86.2% |
| FY2018 | -$78.4M | -141.9% |
| FY2017 | -$32.4M | -25.1% |
| FY2016 | -$25.9M | -145.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026